Journal of Medicinal Chemistry
Article
Methylation and Demethylation by Histone Lysine Methyltransferase
G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4
Proteins. J. Biol. Chem. 2009, 284, 8395−8405.
(13) Yang, L.; Lin, C.; Liu, W.; Zhang, J.; Ohgi, K. A.; Grinstein, J.
D.; Dorrestein, P. C.; Rosenfeld, M. G. ncRNA- and Pc2 methylation-
dependent gene relocation between nuclear structures mediates gene
activation programs. Cell 2011, 147, 773−788.
(14) Chu, C. H.; Wang, L. Y.; Hsu, K. C.; Chen, C. C.; Cheng, H. H.;
Wang, S. M.; Wu, C. M.; Chen, T. J.; Li, L. T.; Liu, R.; Hung, C. L.;
Yang, J. M.; Kung, H. J.; Wang, W. C. KDM4B as a target for prostate
cancer: structural analysis and selective inhibition by a novel inhibitor.
J. Med. Chem. 2014, 57, 5975−5985.
(15) Liu, Y.; Zheng, P.; Liu, Y.; Ji, T.; Liu, X.; Yao, S.; Cheng, X.; Li,
Y.; Chen, L.; Xiao, Z.; Zhou, J.; Li, J. An epigenetic role for PRL-3 as a
regulator of H3K9 methylation in colorectal cancer. Gut 2013, 62,
571−581.
(16) Yang, J.; Jubb, A. M.; Pike, L.; Buffa, F. M.; Turley, H.; Baban,
D.; Leek, R.; Gatter, K. C.; Ragoussis, J.; Harris, A. L. The histone
demethylase JMJD2B is regulated by estrogen receptor alpha and
hypoxia, and is a key mediator of estrogen induced growth. Cancer Res.
2010, 70, 6456−6466.
(17) Walport, L. J.; Hopkinson, R. J.; Schofield, C. J. Mechanisms of
human histone and nucleic acid demethylases. Curr. Opin. Chem. Biol.
2012, 16, 525−534.
(18) McDonough, M. A.; Loenarz, C.; Chowdhury, R.; Clifton, I. J.;
Schofield, C. J. Structural studies on human 2-oxoglutarate dependent
oxygenases. Curr. Opin. Struct. Biol. 2010, 20, 659−672.
(19) Rose, N. R.; McDonough, M. A.; King, O. N.; Kawamura, A.;
Schofield, C. J. Inhibition of 2-oxoglutarate dependent oxygenases.
Chem. Soc. Rev. 2011, 40, 4364−4397.
(20) Thinnes, C. C.; England, K. S.; Kawamura, A.; Chowdhury, R.;
Schofield, C. J.; Hopkinson, R. J. Targeting histone lysine
demethylases - Progress, challenges, and the future. Biochim. Biophys.
Acta, Gene Regul. Mech. 2014, 1839, 1416−1432.
(21) Thalhammer, A.; Mecinovic, J.; Loenarz, C.; Tumber, A.; Rose,
N. R.; Heightman, T. D.; Schofield, C. J. Inhibition of the histone
demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates. Org.
Biomol. Chem. 2011, 9, 127−135.
(22) Majamaa, K.; Hanauske-Abel, H. M.; Gunzler, V.; Kivirikko, K. I.
The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification
of distinct subsites and evidence for 2-oxoglutarate decarboxylation in
a ligand reaction at the enzyme-bound ferrous ion. Eur. J. Biochem.
1984, 138, 239−245.
(23) King, O. N.; Li, X. S.; Sakurai, M.; Kawamura, A.; Rose, N. R.;
Ng, S. S.; Quinn, A. M.; Rai, G.; Mott, B. T.; Beswick, P.; Klose, R. J.;
Oppermann, U.; Jadhav, A.; Heightman, T. D.; Maloney, D. J.;
Schofield, C. J.; Simeonov, A. Quantitative high-throughput screening
identifies 8-hydroxyquinolines as cell-active histone demethylase
inhibitors. PLoS One 2010, 5, e15535.
(24) Hopkinson, R. J.; Tumber, A.; Yapp, C.; Chowdhury, R.; Aik,
W.; Che, K. H.; Li, X. S.; Kristensen, J. B. L.; King, O. N. F.; Chan, M.
C.; Yeoh, K. K.; Choi, H.; Walport, L. J.; Thinnes, C. C.; Bush, J. T.;
Lejeune, C.; Rydzik, A. M.; Rose, N. R.; Bagg, E. A.; McDonough, M.
A.; Krojer, T. J.; Yue, W. W.; Ng, S. S.; Olsen, L.; Brennan, P. E.;
Oppermann, U.; Muller, S.; Klose, R. J.; Ratcliffe, P. J.; Schofield, C. J.;
Kawamura, A. 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-
oxoglutarate oxygenase inhibitor which causes iron translocation.
Chem. Sci. 2013, 4, 3110−3117.
(25) Rose, N. R.; Ng, S. S.; Mecinovic, J.; Lienard, B. M.; Bello, S. H.;
Sun, Z.; McDonough, M. A.; Oppermann, U.; Schofield, C. J. Inhibitor
scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. J.
Med. Chem. 2008, 51, 7053−7056.
(26) Wang, L.; Chang, J.; Varghese, D.; Dellinger, M.; Kumar, S.;
Best, A. M.; Ruiz, J.; Bruick, R.; Pena-Llopis, S.; Xu, J.; Babinski, D. J.;
Frantz, D. E.; Brekken, R. A.; Quinn, A. M.; Simeonov, A.; Easmon, J.;
Martinez, E. D. A small molecule modulates Jumonji histone
demethylase activity and selectively inhibits cancer growth. Nat.
Commun. 2013, 4, 2035.
(27) Luo, X.; Liu, Y.; Kubicek, S.; Myllyharju, J.; Tumber, A.; Ng, S.;
Che, K. H.; Podoll, J.; Heightman, T. D.; Oppermann, U.; Schreiber, S.
L.; Wang, X. A selective inhibitor and probe of the cellular functions of
Jumonji C domain-containing histone demethylases. J. Am. Chem. Soc.
2011, 133, 9451−9456.
(28) Kruidenier, L.; Chung, C. W.; Cheng, Z.; Liddle, J.; Che, K.;
Joberty, G.; Bantscheff, M.; Bountra, C.; Bridges, A.; Diallo, H.;
Eberhard, D.; Hutchinson, S.; Jones, E.; Katso, R.; Leveridge, M.;
Mander, P. K.; Mosley, J.; Ramirez-Molina, C.; Rowland, P.; Schofield,
C. J.; Sheppard, R. J.; Smith, J. E.; Swales, C.; Tanner, R.; Thomas, P.;
Tumber, A.; Drewes, G.; Oppermann, U.; Patel, D. J.; Lee, K.; Wilson,
D. M. A selective jumonji H3K27 demethylase inhibitor modulates the
proinflammatory macrophage response. Nature 2012, 488, 404−408.
(29) Heinemann, B.; Nielsen, J. M.; Hudlebusch, H. R.; Lees, M. J.;
Larsen, D. V.; Boesen, T.; Labelle, M.; Gerlach, L. O.; Birk, P.; Helin,
K. Inhibition of demethylases by GSK-J1/J4. Nature 2014, 514, E1−2.
(30) Woon, E. C.; Tumber, A.; Kawamura, A.; Hillringhaus, L.; Ge,
W.; Rose, N. R.; Ma, J. H.; Chan, M. C.; Walport, L. J.; Che, K. H.; Ng,
S. S.; Marsden, B. D.; Oppermann, U.; McDonough, M. A.; Schofield,
C. J. Linking of 2-oxoglutarate and substrate binding sites enables
potent and highly selective inhibition of JmjC histone demethylases.
Angew. Chem., Int. Ed. 2012, 51, 1631−1634.
(31) Murray, C. W.; Blundell, T. L. Structural biology in fragment-
based drug design. Curr. Opin. Struct. Biol. 2010, 20, 497−507.
(32) Hamada, S.; Kim, T. D.; Suzuki, T.; Itoh, Y.; Tsumoto, H.;
Nakagawa, H.; Janknecht, R.; Miyata, N. Synthesis and activity of N-
oxalylglycine and its derivatives as Jumonji C-domain-containing
histone lysine demethylase inhibitors. Bioorg. Med. Chem. Lett. 2009,
19, 2852−2855.
(33) Hann, M. M.; Leach, A. R.; Harper, G. Molecular complexity
and its impact on the probability of finding leads for drug discovery. J.
Chem. Inf. Model. 2001, 41, 856−864.
(34) Hann, M. M.; Keseru, G. M. Finding the sweet spot: the role of
nature and nurture in medicinal chemistry. Nat. Rev. Drug Discovery
2012, 11, 355−365.
(35) Murray, C. W.; Carr, M. G.; Callaghan, O.; Chessari, G.;
Congreve, M.; Cowan, S.; Coyle, J. E.; Downham, R.; Figueroa, E.;
Frederickson, M.; Graham, B.; McMenamin, R.; O’Brien, M. A.; Patel,
S.; Phillips, T. R.; Williams, G.; Woodhead, A. J.; Woolford, A. J.
Fragment-based drug discovery applied to Hsp90. Discovery of two
lead series with high ligand efficiency. J. Med. Chem. 2010, 53, 5942−
5955.
(36) Bembenek, S. D.; Tounge, B. A.; Reynolds, C. H. Ligand
efficiency and fragment-based drug discovery. Drug Discovery Today
2009, 14, 278−283.
(37) Lipinski, C.; Hopkins, A. Navigating chemical space for biology
and medicine. Nature 2004, 432, 855−861.
(38) Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.;
Coleman, R. G. ZINC: a free tool to discover chemistry for biology. J.
Chem. Inf. Model. 2012, 52, 1757−1768.
(39) Mysinger, M. M.; Shoichet, B. K. Rapid context-dependent
ligand desolvation in molecular docking. J. Chem. Inf. Model. 2010, 50,
1561−1573.
(40) Meng, E. C.; Shoichet, B. K.; Kuntz, I. D. Automated Docking
with Grid-Based Energy Evaluation. J. Comput. Chem. 1992, 13, 505−
524.
(41) Gilson, M. K.; Honig, B. The inclusion of electrostatic hydration
energies in molecular mechanics calculations. J. Comput.-Aided Mol.
Des. 1991, 5, 5−20.
(42) Irwin, J. J.; Raushel, F. M.; Shoichet, B. K. Virtual screening
against metalloenzymes for inhibitors and substrates. Biochemistry
2005, 44, 12316−12328.
(43) Babaoglu, K.; Simeonov, A.; Irwin, J. J.; Nelson, M. E.; Feng, B.;
Thomas, C. J.; Cancian, L.; Costi, M. P.; Maltby, D. A.; Jadhav, A.;
Inglese, J.; Austin, C. P.; Shoichet, B. K. Comprehensive mechanistic
analysis of hits from high-throughput and docking screens against beta-
lactamase. J. Med. Chem. 2008, 51, 2502−2511.
(44) Mysinger, M. M.; Weiss, D. R.; Ziarek, J. J.; Gravel, S.; Doak, A.
K.; Karpiak, J.; Heveker, N.; Shoichet, B. K.; Volkman, B. F. Structure-
R
J. Med. Chem. XXXX, XXX, XXX−XXX